SCHEMBL9976606

SCHEMBL9976606

CC(=O)CCC(=O)OCCOCCOCCOCCOC(=O)NCCc1ccc(O)c(O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.54
HSD17B10 Q99714 4/20 0.54
HPGD P15428 4/20 0.54
HIF1A Q16665 3/20 0.54
KDM4E B2RXH2 3/20 0.54
LMNA P02545 3/20 0.54
BLM P54132 3/20 0.54
ALDH1A1 P00352 3/20 0.54
PTGS1 P23219 1/20 0.54
APP P05067 3/20 0.53
YWHAG P61981 1/20 0.47
TRPV1 Q8NER1 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SLC7A5 Q01650 1/20 0.45
ALOX12 P18054 2/20 0.43
PTGS2 P35354 1/20 0.43
JAK3 P52333 1/20 0.43
ALPL P05186 1/20 0.43
TP53 P04637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10069007 0.84 MAPT (0.51) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL10069008 0.83 MAPT (0.55) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL9976615 0.80 APP (0.54) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL4448682 0.78 MAPT (0.62) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL19785179 0.77 MAPT (0.69) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL28557038 0.77 MAPT (0.65) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL31542971 0.76 MAPT (0.56) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL18998959 0.75 APP (0.73) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL20730239 0.74 APP (0.77) MAPTHSD17B10HPGDHIF1AKDM4E
SCHEMBL21388223 0.73 MAPT (0.59) MAPTHSD17B10HPGDHIF1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157824-A1 MRI AND OPTICAL ASSAYS FOR PROTEASES NANOSCALE CORPORATION (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157824-A1 MRI AND OPTICAL ASSAYS FOR PROTEASES PREP, HPN, ADAM9 MAPT 905/4885HSD17B10 3050/4885HPGD 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.